The Best Treatment for Covid Is Still Too Hard to Get

We’re still asking people with Covid to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.

I experienced the barriers first-hand last week after my mother texted to say that this summer’s Covid wave had finally caught up with her. My first thought was to make sure she quickly started taking the antiviral. You’d think she would be an ideal candidate, because she is in her 70s with an underlying health condition. But it took a daylong effort to get her the medicine, one that involved multiple emails, phone calls with three different doctor’s offices, a telehealth visit and a bit of pharmacy-hopping to find one that had the pills in stock.